why is compounded tirzepatide still being sold FDA ban on tirzepatide: Switch to name brand medications Compounded Tirzepatide for Weight Loss

Hail Damage Hailstorms may seem rare in Miami, but they can happen

April 11 Product: AstraZenecas Fasnera Indication: Asthma AstraZeneca won a label expansion Thursday for Fasnera, a subcutaneous IL-5 receptor blocker, for the add-on maintenance treatment of severe eosinophilic asthma in kids 6 to 11 years of age

For instance, being treated differently at work or in personal relationships might feel unsettling

The SURMOUNT-4 trial provides the clearest long-term data

A study published in a quality-of-life journal found that patients who switched from oral semaglutide to tirzepatide due to insufficient weight reduction experienced significant improvements in quality of life as early as 3 months after the switch

But another striking effect that has emerged is that these medications also decrease the desire for things other than food- alcohol, nicotine and opioids